首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1629595

护理软体市场：按产品、按交付形式、按最终用户、按地区

Long-term Care Software Market, By Product, By Mode of Delivery, By End User, By Geography

出版日期: 2024年11月26日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2024 年全球护理软体市场价值估计为 54 亿美元，预计 2031 年将达到 90.1 亿美元，2024 年至 2031 年的复合年增长率为 7.6%。

报告范围		报告详细信息
基准年	2023	2024 年的市场规模	54亿美元
效能资料	2019 年至 2023 年	预测期	2024 年至 2031 年
预测期间 2024 年至 2031 年复合年增长率：	7.60％	2031 年价值预测	90.1亿美元

图。

护理软体有助于管理老年人住宅设施、成人日托、辅助生活之家和疗养院。简化与居民相关的行政业务，包括药物管理、计费和服务时间追踪。全球老龄人口日益增多，容易患慢性疾病和残疾，这推动了对此类设施的需求。此外，住院医疗费用的上涨也推动了对优质居家照护的需求。这促使护理提供者投资于软体解决方案，以帮助他们提供优质服务，同时保持生产力并遵守法规。随着人们对老年护理选择的认识不断提高，市场预计将稳步增长。

市场动态：

推动全球老年护理软体市场发展的关键驱动因素是导致老年人残疾的慢性病患病率上升、医疗成本增加促使更多人采用家庭护理解决方案，以及强制在医疗保健中使用数位工具的法规的实施。然而，安装和维护此类软体的成本高昂，以及某些地区熟练护理人员的短缺，减缓了其普及速度。机会在于开发更强大的云端基础的版本并整合人工智慧功能以远端监控健康参数。市场开发公司还可以探索人口老化的新兴国家的商机。

本研究的主要特点

本报告对全球护理软体市场进行了详细分析，并以 2023 年为基准年，给出了预测期（2024-2031 年）的市场规模和年复合成长率（CAGR%）。

它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

它根据公司亮点、产品系列、关键亮点、财务业绩和策略等参数，对全球老年护理软体市场的主要企业进行了概述。

主要企业包括雅培 (Abbott)、美敦力 (Medtronic)、Getinge AB、Abiomed、Terumo Corporation、波士顿科学 (Boston Scientific)、罗氏公司 (F. Hoffmann-La Roche Ltd)、拜耳公司 (Bayer AG)、Viatris Inc.、Par Pharmacetical、Xerx 啊和 Chiesi Farmaceutici SpA。

本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

相关人员将透过用于分析全球护理软体市场的各种策略矩阵更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	US$ 5.40 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	7.60%	2031 Value Projection:	US$ 9.01 Bn

Long-term care software helps in the management of senior housing facilities, adult daycare, assisted living, and nursing homes. It streamlines administrative tasks related to residents such as medication management, billing, and tracking service hours. The rising geriatric population globally prone to chronic diseases and disabilities has boosted the need for such facilities. Additionally, the demand for quality care at home has also been on the rise owing to greater medical costs of inpatient care. This has prompted care providers to invest in software solutions that aid in providing quality services while maintaining productivity and regulatory compliance. The market is expected to grow steadily as awareness about senior care options increases.

Market Dynamics:

The key drivers fueling the global long-term care software market include growing prevalence of chronic diseases leading to disabilities among elderly, increasing healthcare costs prompting greater adoption of home-based care solutions, and implementation of regulations mandating use of digital tools in healthcare. However, high installation and maintenance costs of such software as well as lack of skilled nursing staff in some regions are slowing down adoption. The opportunity lies in the development of more robust cloud-based versions and integration of AI capabilities for remotely monitoring health parameters. Market players could also explore opportunities in developing countries witnessing rise in aging population.

Key Features of the Study:

This report provides in-depth analysis of the global long-term care software market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global long-term care software market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott, Medtronic, Getinge AB, Abiomed, Terumo Corporation, Boston Scientific, F. Hoffmann-La Roche Ltd, Bayer AG, Viatris Inc., Par Pharmaceutical, AstraZeneca, Zoll Medical Corporation, Xenios AG (part of Fresenius Medical Care), Windtree Therapeutics, and Chiesi Farmaceutici S.p.A.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global long-term care software market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global long-term care software market

Market Segmentation

By Product Insights (Revenue, USD Bn 2019 - 2031)
- Electronic Health Records (EHR)
- Remote Patient Monitoring Systems
- Revenue Cycle Management (RCM)
- Clinical Decision Support Systems
- E-prescribing
- Real-Time Location Systems
- Electronic Medication Administration Record (eMAR)
- E-prescribing
- Billing, Invoicing, and Scheduling Software
- Others
By Mode of Delivery Insights (Revenue, USD Bn, 2019 - 2031)
- Cloud-Based
- Web-Based
- On-Premise
By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Home Healthcare Agencies
- Hospice & Palliative Care
- Nursing Homes
- Assisted Living Facilities
- Others
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Abbott
- Medtronic
- Getinge AB
- Abiomed
- Terumo Corporation
- Boston Scientific
- Hoffmann-La Roche Ltd
- Bayer AG
- Viatris Inc.
- Par Pharmaceutical
- AstraZeneca
- Zoll Medical Corporation
- Xenios AG (part of Fresenius Medical Care)
- Windtree Therapeutics
- Chiesi Farmaceutici S.p.A.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Long-term Care Software Market, By Product
- Global Long-term Care Software Market, By Mode of Delivery
- Global Long-term Care Software Market, By End User
- Global Long-term Care Software Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Long-term Care Software Market, By Product, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Electronic Health Records (EHR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Remote Patient Monitoring Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Revenue Cycle Management (RCM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Clinical Decision Support Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
E-prescribing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Real-Time Location Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Electronic Medication Administration Record (eMAR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
E-prescribing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Billing, Invoicing, and Scheduling Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Long-term Care Software Market, By Mode of Delivery, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Cloud-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Web-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
On-Premise
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Long-term Care Software Market, By End User, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Home Healthcare Agencies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Hospice & Palliative Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nursing Homes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Assisted Living Facilities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Long-term Care Software Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic
Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Getinge AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abiomed
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boston Scientific
Hoffmann-La Roche Ltd
Bayer AG
Viatris Inc.
Par Pharmaceutical
AstraZeneca
Zoll Medical Corporation
Xenios AG (part of Fresenius Medical Care)
Windtree Therapeutics
Chiesi Farmaceutici S.p.A.

9. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

护理软体市场：按产品、按交付形式、按最终用户、按地区